Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Udenafil vs Amlodipine in Secondary Raynaud Phenomenon
NCT01280266Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jan 2011
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of udenafil in Raynaud phenomenon, sponsored by Seoul National University Hospital. Started Jan 2011; status: completed.
02
Drugs
udenafil
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT01280266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01280266.